<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02722655</url>
  </required_header>
  <id_info>
    <org_study_id>2015-018</org_study_id>
    <nct_id>NCT02722655</nct_id>
  </id_info>
  <brief_title>Cohort of Mexican Children With Diabetes Mellitus (CMC-DM)</brief_title>
  <acronym>CMC-DM</acronym>
  <official_title>Characteristics and Evolution of Diabetes Mellitus in Mexican Children: Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Regional de Alta Especialidad del Bajio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Regional de Alta Especialidad del Bajio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is the identification of complications in diabetes mellitus pediatric
      patients and to compare the clinical, anthropometric, and biochemical characteristics between
      children in the different types of diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes mellitus is characterized by hyperglycemia resulting from defects in insulin
      secretion and/or insulin resistance in target tissues. This study identify the influence of
      pathogenic factors on the evolution of diabetes mellitus and in the presence of chronic
      complications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetic retinopathy</measure>
    <time_frame>year 3</time_frame>
    <description>A microvascular complication determined by ophthalmological evaluation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral diabetic neuropathy</measure>
    <time_frame>year 5</time_frame>
    <description>A microvascular complication determined by neurological exam in either foot</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nerve damage</measure>
    <time_frame>year 5</time_frame>
    <description>A microvascular complication determined by nerve conduction study in either foot</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microalbuminuria</measure>
    <time_frame>annual</time_frame>
    <description>A microvascular complication determined by urine albumin excretion &gt;= 30 mg/day</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac function</measure>
    <time_frame>year 5</time_frame>
    <description>A cardiovascular risk indicator determined by echocardiogram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive evaluation</measure>
    <time_frame>year 3</time_frame>
    <description>Determined by scores on the Mini-Mental State Examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intelligence quotient evaluation</measure>
    <time_frame>year 3</time_frame>
    <description>Determined by Intelligence quotient test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>annual</time_frame>
    <description>Determined by body mass index (BMI) percentiles computed from physical measurements of height and weight and corresponding percentile tables</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>annual</time_frame>
    <description>Determined by HbA1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beta cell function</measure>
    <time_frame>annual</time_frame>
    <description>Determined by fasting C peptide</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pancreatic autoimmunity</measure>
    <time_frame>onset of diabetes</time_frame>
    <description>Determined by pancreas autoantibodies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>annual</time_frame>
    <description>Determined by insulin sensitivity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alpha cell function</measure>
    <time_frame>year 5</time_frame>
    <description>Determined by glucagon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperlipidemia</measure>
    <time_frame>annual</time_frame>
    <description>Determined by lipid profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypothyroidism</measure>
    <time_frame>annual</time_frame>
    <description>Determined by thyroid profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypertension</measure>
    <time_frame>annual</time_frame>
    <description>Determined by collection of systolic and diastolic blood pressure and calculation of their percentile values</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Type 1 diabetes mellitus</arm_group_label>
    <description>Sudden onset of symptoms and non-overweight/obese</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 diabetes mellitus</arm_group_label>
    <description>Insidious onset of symptoms and overweight/obese</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 1.5 diabetes mellitus</arm_group_label>
    <description>Overlap of type 1 and type2 diabetes mellitus clinical characteristics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other types of diabetes mellitus</arm_group_label>
    <description>According American Diabetes Association criteria</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children and adolescents (boys and girls) from 1 months to 17 years of age that had
        recently been diagnosed with diabetes mellitus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with confirmed diagnosis of diabetes mellitus

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María L Evia-Viscarra</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatric Endocrinology, Hospital Regional de Alta Especialidad del Bajío</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>María L Evia-Viscarra</last_name>
    <phone>+52 (477) 2672000</phone>
    <phone_ext>1405</phone_ext>
    <email>mlola.evia@hraeb.gob.mx</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Regional de Alta Especialidad del Bajío</name>
      <address>
        <city>Leon</city>
        <state>Guanajuato</state>
        <zip>37660</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María L Evia-Viscarra</last_name>
      <phone>+52 (477) 2672000</phone>
      <phone_ext>1504</phone_ext>
      <email>mlola.evia@hraeb.gob.mx</email>
    </contact>
    <investigator>
      <last_name>Edel R Rodea-Montero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rodolfo Guardado-Mendoza</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2016</study_first_submitted>
  <study_first_submitted_qc>March 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2016</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Regional de Alta Especialidad del Bajio</investigator_affiliation>
    <investigator_full_name>Maria Lola Evia-Viscarra</investigator_full_name>
    <investigator_title>Pediatric Endocrinologist</investigator_title>
  </responsible_party>
  <keyword>Pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

